Antibody

An antibody (Ab), also known as an immunoglobulin (Ig), is a large, Y-shaped protein produced primarily by plasma cells that is utilized by the immune system to identify, neutralize, and eliminate pathogens such as bacteria, viruses, and fungi.

Structure

Antibodies are glycoproteins belonging to the immunoglobulin superfamily. The basic structural unit of an antibody is a tetramer consisting of two identical heavy (H) chains and two identical light (L) chains linked by disulfide bonds. Each chain is composed of a series of globular regions known as immunoglobulin domains.

The Y-shaped structure of an antibody can be divided into distinct functional regions. The two arms of the "Y" form the Fragment antigen-binding (Fab) region, which contains the variable domains of both the heavy and light chains. These variable regions, particularly the complementarity-determining regions (CDRs), are responsible for recognizing and binding to specific antigens with high affinity. The stem of the "Y" forms the Fragment crystallizable (Fc) region, which consists of the constant domains of the heavy chains. The Fc region mediates the effector functions of the antibody by interacting with Fc receptors on immune cells and components of the complement system.

Isotypes

Mammalian antibodies are classified into five main isotypes or classes based on the type of heavy chain they possess: IgG, IgA, IgM, IgE, and IgD. Each isotype has a distinct biological role and is deployed in different stages of the immune response. IgG is the most abundant isotype in blood and extracellular fluid, providing long-term protection against circulating pathogens. IgA is predominantly found in mucosal areas, such as the respiratory and gastrointestinal tracts, preventing microbial colonization. IgM is the first antibody produced in response to an infection and is highly effective at activating the complement system. IgE plays a crucial role in defending against parasitic infections and is the primary mediator of allergic reactions. IgD functions mainly as an antigen receptor on the surface of naive B cells.

Function and Mechanisms of Action

The primary function of an antibody is to bind to its specific antigen, thereby preventing the pathogen from entering host cells, a process known as neutralization. Beyond direct binding, antibodies facilitate pathogen clearance through several effector mechanisms. Opsonization occurs when antibodies coat the surface of a pathogen, marking it for phagocytosis by macrophages and neutrophils. Antibodies can also activate the classical complement pathway via their Fc regions, leading to the formation of the membrane attack complex that lyses the pathogen. Additionally, antibodies can recruit natural killer (NK) cells to destroy target cells through a process called antibody-dependent cellular cytotoxicity (ADCC).

Production and Genetic Diversity

Antibodies are produced by B lymphocytes (B cells). Upon encountering a specific antigen, naive B cells are activated, often with the help of T helper cells, and differentiate into antibody-secreting plasma cells or long-lived memory B cells. The immense diversity of the antibody repertoire is generated through several genetic mechanisms during B cell development. V(D)J recombination randomly combines variable (V), diversity (D), and joining (J) gene segments to create unique variable regions. Following antigen exposure, somatic hypermutation introduces point mutations into the variable regions, allowing for affinity maturation, while class switch recombination enables a B cell to change the isotype of the antibody it produces without altering its antigen specificity.

Clinical Applications

Antibodies have revolutionized both medical diagnostics and therapeutics. In diagnostics, the high specificity of antibodies is exploited in techniques such as enzyme-linked immunosorbent assays (ELISA), Western blotting, and immunohistochemistry to detect the presence of specific proteins, pathogens, or biomarkers in patient samples.

In therapeutics, monoclonal antibodies (mAbs) have become a cornerstone of modern medicine. Produced using hybridoma technology or recombinant DNA methods, mAbs are engineered to target specific disease-related molecules. They are widely used in oncology to target tumor-specific antigens, in autoimmune diseases to neutralize pro-inflammatory cytokines, and in infectious diseases to provide passive immunity. Recent advancements have also led to the development of bispecific antibodies, which can bind two different antigens simultaneously, and antibody-drug conjugates (ADCs), which deliver cytotoxic drugs directly to target cells.

History

The concept of antibodies was first introduced in the late 19th century. In 1890, Emil von Behring and Kitasato Shibasaburō discovered the presence of diphtheria and tetanus antitoxins in the blood of immunized animals, laying the foundation for the study of humoral immunity. The term "antibody" was coined by Paul Ehrlich in 1891. A major breakthrough occurred in 1975 when Georges Köhler and César Milstein developed the hybridoma technique, enabling the mass production of identical monoclonal antibodies. This innovation earned them the Nobel Prize in Physiology or Medicine in 1984 and paved the way for the development of numerous life-saving biologic drugs.